Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stents | 5 | 2025 | 498 | 2.380 |
Why?
|
| Radiography, Interventional | 3 | 2025 | 82 | 2.300 |
Why?
|
| Iliac Vein | 3 | 2025 | 10 | 1.580 |
Why?
|
| Alloys | 2 | 2023 | 30 | 1.570 |
Why?
|
| Vascular Diseases | 2 | 2021 | 83 | 1.260 |
Why?
|
| Catheter Ablation | 2 | 2022 | 156 | 1.250 |
Why?
|
| Pulmonary Embolism | 2 | 2026 | 196 | 0.920 |
Why?
|
| Contrast Media | 3 | 2023 | 432 | 0.910 |
Why?
|
| Ablation Techniques | 1 | 2025 | 26 | 0.910 |
Why?
|
| Infusions, Intra-Arterial | 2 | 2024 | 13 | 0.890 |
Why?
|
| Stellate Ganglion | 1 | 2024 | 5 | 0.870 |
Why?
|
| Venous Thrombosis | 2 | 2025 | 112 | 0.870 |
Why?
|
| Cryosurgery | 1 | 2024 | 28 | 0.860 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 308 | 0.840 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2025 | 114 | 0.840 |
Why?
|
| Portal Vein | 1 | 2024 | 39 | 0.830 |
Why?
|
| Kidney Neoplasms | 1 | 2025 | 173 | 0.810 |
Why?
|
| Thrombectomy | 1 | 2026 | 256 | 0.800 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2024 | 1656 | 0.780 |
Why?
|
| Treatment Outcome | 8 | 2026 | 5792 | 0.760 |
Why?
|
| Tachycardia, Ventricular | 1 | 2024 | 131 | 0.750 |
Why?
|
| Retrospective Studies | 12 | 2026 | 6872 | 0.740 |
Why?
|
| Thyroid Nodule | 1 | 2022 | 15 | 0.740 |
Why?
|
| Vena Cava Filters | 1 | 2022 | 23 | 0.730 |
Why?
|
| Vena Cava, Inferior | 1 | 2022 | 33 | 0.720 |
Why?
|
| Venous Insufficiency | 1 | 2021 | 6 | 0.720 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2022 | 56 | 0.710 |
Why?
|
| Epilepsy | 3 | 2022 | 113 | 0.710 |
Why?
|
| Anesthetics, Local | 1 | 2022 | 73 | 0.690 |
Why?
|
| Radiology | 2 | 2023 | 263 | 0.690 |
Why?
|
| Embolization, Therapeutic | 1 | 2024 | 333 | 0.650 |
Why?
|
| Image-Guided Biopsy | 1 | 2020 | 50 | 0.630 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 55 | 0.630 |
Why?
|
| Arthritis, Infectious | 1 | 2019 | 20 | 0.610 |
Why?
|
| Knee Prosthesis | 1 | 2019 | 11 | 0.610 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 83 | 0.610 |
Why?
|
| Prosthesis-Related Infections | 1 | 2019 | 34 | 0.590 |
Why?
|
| Lymphography | 3 | 2023 | 11 | 0.570 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 134 | 0.510 |
Why?
|
| Humans | 32 | 2026 | 65140 | 0.510 |
Why?
|
| Time Factors | 4 | 2026 | 3762 | 0.490 |
Why?
|
| Vascular Patency | 2 | 2025 | 134 | 0.410 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 324 | 0.400 |
Why?
|
| Middle Aged | 9 | 2026 | 18273 | 0.370 |
Why?
|
| Aged | 6 | 2026 | 14965 | 0.350 |
Why?
|
| Radiology, Interventional | 2 | 2023 | 31 | 0.350 |
Why?
|
| Sheep | 2 | 2022 | 189 | 0.350 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2024 | 94 | 0.340 |
Why?
|
| Risk Factors | 3 | 2026 | 5429 | 0.330 |
Why?
|
| Constriction, Pathologic | 2 | 2021 | 130 | 0.330 |
Why?
|
| Male | 11 | 2026 | 31047 | 0.320 |
Why?
|
| Female | 12 | 2026 | 34018 | 0.310 |
Why?
|
| Biomechanical Phenomena | 2 | 2022 | 293 | 0.310 |
Why?
|
| Hepatic Artery | 2 | 2024 | 22 | 0.260 |
Why?
|
| Water | 3 | 2023 | 314 | 0.240 |
Why?
|
| Tumor Burden | 1 | 2025 | 75 | 0.230 |
Why?
|
| Tertiary Care Centers | 1 | 2026 | 111 | 0.230 |
Why?
|
| Pandemics | 2 | 2020 | 674 | 0.230 |
Why?
|
| Liver Regeneration | 1 | 2024 | 20 | 0.210 |
Why?
|
| Acute Disease | 1 | 2026 | 663 | 0.210 |
Why?
|
| Animals | 5 | 2023 | 21345 | 0.210 |
Why?
|
| Tarsal Bones | 1 | 2023 | 3 | 0.200 |
Why?
|
| Ventricular Fibrillation | 1 | 2024 | 107 | 0.200 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 1698 | 0.200 |
Why?
|
| Minnesota | 1 | 2023 | 45 | 0.200 |
Why?
|
| Prosthesis Design | 1 | 2023 | 220 | 0.190 |
Why?
|
| Mentors | 1 | 2023 | 118 | 0.180 |
Why?
|
| Swine | 1 | 2023 | 394 | 0.180 |
Why?
|
| Consciousness | 1 | 2022 | 12 | 0.180 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2022 | 23 | 0.180 |
Why?
|
| Angioplasty | 1 | 2022 | 53 | 0.180 |
Why?
|
| Device Removal | 1 | 2022 | 64 | 0.180 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 220 | 0.180 |
Why?
|
| Awareness | 1 | 2022 | 73 | 0.170 |
Why?
|
| Saphenous Vein | 1 | 2021 | 51 | 0.170 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2021 | 16 | 0.170 |
Why?
|
| Risk Assessment | 2 | 2026 | 2102 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 1113 | 0.160 |
Why?
|
| Finite Element Analysis | 1 | 2020 | 13 | 0.160 |
Why?
|
| Sternum | 1 | 2020 | 29 | 0.160 |
Why?
|
| Sus scrofa | 1 | 2020 | 30 | 0.160 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 286 | 0.160 |
Why?
|
| Leptospermum | 1 | 2020 | 1 | 0.160 |
Why?
|
| Phloroglucinol | 1 | 2020 | 2 | 0.160 |
Why?
|
| Sesquiterpenes | 1 | 2020 | 5 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2022 | 298 | 0.160 |
Why?
|
| Gases | 1 | 2019 | 19 | 0.150 |
Why?
|
| Disease Progression | 1 | 2024 | 1220 | 0.150 |
Why?
|
| Cervical Vertebrae | 1 | 2020 | 121 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2022 | 483 | 0.150 |
Why?
|
| Self Report | 1 | 2022 | 390 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 643 | 0.140 |
Why?
|
| Spinal Fusion | 1 | 2020 | 161 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 180 | 0.140 |
Why?
|
| STAT4 Transcription Factor | 1 | 2017 | 7 | 0.140 |
Why?
|
| T-Box Domain Proteins | 1 | 2017 | 38 | 0.130 |
Why?
|
| Cognition | 1 | 2022 | 508 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 205 | 0.130 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 112 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 219 | 0.130 |
Why?
|
| Virus Diseases | 1 | 2017 | 117 | 0.120 |
Why?
|
| Adult | 5 | 2025 | 17358 | 0.120 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 5614 | 0.110 |
Why?
|
| Spatial Behavior | 1 | 2014 | 9 | 0.100 |
Why?
|
| Space Perception | 1 | 2014 | 19 | 0.100 |
Why?
|
| Consciousness Disorders | 1 | 2014 | 10 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2014 | 101 | 0.100 |
Why?
|
| User-Computer Interface | 1 | 2014 | 125 | 0.100 |
Why?
|
| Automobile Driving | 1 | 2014 | 53 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 2293 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2020 | 800 | 0.090 |
Why?
|
| Intracranial Hemorrhages | 2 | 2024 | 69 | 0.090 |
Why?
|
| Radiography | 2 | 2023 | 555 | 0.090 |
Why?
|
| Canada | 2 | 2021 | 154 | 0.080 |
Why?
|
| Tranexamic Acid | 1 | 2024 | 9 | 0.050 |
Why?
|
| Antifibrinolytic Agents | 1 | 2024 | 19 | 0.050 |
Why?
|
| Infusion Pumps | 1 | 2023 | 8 | 0.050 |
Why?
|
| Edema | 1 | 2023 | 42 | 0.050 |
Why?
|
| Ethiodized Oil | 1 | 2023 | 7 | 0.050 |
Why?
|
| Child | 2 | 2023 | 4607 | 0.050 |
Why?
|
| Radiologists | 1 | 2023 | 93 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2024 | 739 | 0.050 |
Why?
|
| Immunoproteins | 1 | 2021 | 2 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 48 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 19 | 0.040 |
Why?
|
| Ketones | 1 | 2020 | 6 | 0.040 |
Why?
|
| Benzophenones | 1 | 2020 | 20 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2024 | 261 | 0.040 |
Why?
|
| Textiles | 1 | 2020 | 10 | 0.040 |
Why?
|
| Diskectomy | 1 | 2020 | 38 | 0.040 |
Why?
|
| Masks | 1 | 2020 | 20 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 45 | 0.040 |
Why?
|
| Embolectomy | 1 | 2019 | 15 | 0.040 |
Why?
|
| Biomimetics | 1 | 2020 | 31 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 173 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 316 | 0.040 |
Why?
|
| Biomarkers | 1 | 2024 | 1480 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 178 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2019 | 195 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 8 | 0.030 |
Why?
|
| Germinal Center | 1 | 2017 | 39 | 0.030 |
Why?
|
| Interleukins | 1 | 2017 | 88 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 460 | 0.030 |
Why?
|
| Polymers | 1 | 2020 | 332 | 0.030 |
Why?
|
| Health Personnel | 1 | 2021 | 384 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 171 | 0.030 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 213 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 991 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 574 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 616 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 734 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 2244 | 0.030 |
Why?
|
| Young Adult | 1 | 2024 | 4809 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2024 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1386 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1630 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 3485 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1050 | 0.020 |
Why?
|
| United States | 1 | 2020 | 8093 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 11119 | 0.010 |
Why?
|